Commentary on the paper "The heartbeat evoked potential is a questionable biomarker in nightmare disorder: A replication study. By Bogdany, T., Perakakis, P., Bodizs, R., Simor, P., 2021. Neuroimage Clin 33, 102933".
Neuroimage Clin September 19, 2022 DOI: 10.1016/j.nicl.2022.103196 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractThis commentary critically examines a replication study on nightmare disorder and the heartbeat evoked potential (HEP). It contends that the original study's negative findings may stem from methodological limitations rather than definitively disproving HEP's utility as a biomarker. The authors argue that the replication attempt, while valuable, does not conclusively rule out a role for HEP in nightmare disorder due to issues such as sample characteristics and analytical choices. They propose that further research with refined methods is needed before dismissing HEP as a biomarker.
Study at a glance
| Characteristics | Commentary Peer reviewed |
|---|---|
| Key finding | Argues that the replication study's negative findings on the heartbeat evoked potential in nightmare disorder are not definitive due to methodological concerns. |
Abstract
Commentary on the paper "The heartbeat evoked potential is a questionable biomarker in nightmare disorder: A replication study. By Bogdany, T., Perakakis, P., Bodizs, R., Simor, P., 2021. Neuroimage Clin 33, 102933".